Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of X0002 Spray in Knee Osteoarthritis
NCT03691818Phase 2Completed
- Start
- Jul 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ibuprofenamine hydrochloride in osteoarthritis (OA) (9 arms). Primary endpoint: Change of the Subject's Target OA Knee Compared to the Baseline as Assessed by WOMAC at 12 weeks. Started Jul 2018; status: completed.
02
Drugs
ibuprofenamine hydrochloride
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03691818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03691818.